Northrop Grumman cut as it trades at a 25% premium to peers, says Barclays

This post was originally published on this site

https://i-invdn-com.investing.com/news/LYNXNPEB8F1AQ_M.jpg

The analysts said they are downgrading the stock to reflect a lower forecast for FCF during the ramp period for B-21/GBSD over the next several years.

“Our lower forecast is driven by our view that NOC’s margins are likely to deteriorate more than expected, diluting a significant portion of growth that is seen on the outlook for B-21/GBSD,” the analysts wrote. “As we now see NOC outgrowing peers by less, we believe a smaller valuation premium is warranted.”

They explained that they still see a superior revenue growth profile for NOC compared to its peers. However, they also now see margins falling to ~10% as B-21/GBSD production ramps up.

“We estimate that NOC trades at 25% premium to its peers (on 2025) on average, which we think will compress,” said the analysts.

NOC shares are down more than 1% at the time of writing.